The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD1 inhibition in soft-tissue sarcomas with tertiary lymphoid structures: A multicenter phase II trial.
 
Antoine Italiano
Consulting or Advisory Role - Bayer; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); Merck (Inst); MSD (Inst); Roche (Inst)
 
Alban Bessede
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Sophie Piperno-Neumann
Consulting or Advisory Role - Immunocore
Research Funding - MSD (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer/Ipsen
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Francois Bertucci
No Relationships to Disclose
 
Maud Toulmonde
No Relationships to Disclose
 
Carine A. Bellera
No Relationships to Disclose
 
Jean-Philippe Guegan
No Relationships to Disclose
 
Catherine Sautes-Fridman
No Relationships to Disclose
 
Antoine Bougoüin
No Relationships to Disclose
 
Coralie Cantarel
No Relationships to Disclose
 
Francois Le Loarer
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Wolf-Herman Fridman
No Relationships to Disclose